Archive for 2008

  • 楢原知里、吉村和久、畑田万紀子、原田恵嘉、松下修三:中和抗体高感受性R5臨床分離株の抗V3抗体によるin vitro中和逃避ウイルス誘導. 第22回日本エイズ学会学術集会・総会.  2008.11.26-11.28. 大阪

  • 畑田万紀子、吉村和久、石川哲也、原田恵嘉、松下修三: V2領域のN-glycosylation site挿入が抗V3中和抗体エスケープに及ぼす影響. 第22回日本エイズ学会学術集会・総会.  2008.11.26-11.28. 大阪

  • 吉村和久、原田恵嘉、畑田万紀子、増野弘幸、玉村啓和、松下修三: CD4 mimic small compoundのin vitro耐性誘導による結合部位の予測. 第22回日本エイズ学会学術集会・総会.  2008.11.26-11.28. 大阪

  • Narahara, C., Yoshimura, K, Hatada, M., Harada ,S., Matsushita, S.: Different mutation in HIV-1 gp120 V3-tip regin for escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection with low or high concentration of the Mab. 9th Kumamoto AIDS Seminar. Sep. 18-19, 2008, Aso, Kumamoto.

  • Hatada, M., Yoshimura, K, Ishikawa T., Harada S., Matsushita S.: The impact of an N-linked glycosylation site insertion in HIV-1 gp120 region to escape from a potent neutralization anti-V3 monoclonal antibody. 9th Kumamoto AIDS Seminar. Sep. 18-19, 2008, Aso, Kumamoto.

  • Yoshimura, K, Hatada, M., Harada S., Shibata J., Masuo, H., Tamamura, H., Matsushita S.: In vitro induction of human immunodeficienby virus type 1 variants resistant to a low-molecular CD4 mimic compound. 9th Kumamoto AIDS Seminar. Sep. 18-19, 2008, Aso, Kumamoto

  • Ryo, A., Tsurutani, N., Ohba, K., Kimura, R., Komano, J., Nishi, M., Soeda,H., Hattori,S., Perrem, K., Yamamoto, M., Chiba, J., Mimaya, J., Yoshimura, K., Matsushita, S., Honda, M., Yoshimura, A., Sawasaki, T., Aoki, I., Morikawa, Y., and Yamamoto, N. SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag. Proc Natl Acad Sci U S A. 105:294-299, 2008.

  • Ikeda T, Ohsugi T, Kimura T, Matsushita S., Maeda Y, Harada S, Koito A. The anti-retroviral potency of APOBEC1 deaminase from small animal species. Nuleic Acids Research, 36(21): 6859-6871, 2008.

  • Yoshimura, K, Shibata J., Honda, A., Yamada, Y., Nasuo, H., Tamamura, H., Matsushita S.:In vitro induction of human immunodeficienby virus type 1 variants resistant to a low-molecular CD4 mimic compound, N- (4- Chlorophenyl) -N’ – (2,2,6,6-tetramethylpiperidin- 4-yl) – oxalamide (NBD-556). 15th Conference on Retroviruses and Opportunistic infections. Feb. 3-6, 2008, Boston, USA.

  • Matsushita S., Nishida, Y., Shibata J., Honda A., Yoshimura, K: Broad cross-neutralization mediated by combination of anti-V3 and CD4 binding site antibodies in an HIV-1 infected patient with long-term non-progressie disease. 15th Conference on Retroviruses and Opportunistic infections. Feb. 3-6, 2008, Boston, USA